These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8632772)

  • 1. Dopamine D2L receptors stimulate Na+/K(+)-ATPase activity in murine LTK- cells.
    Yamaguchi I; Walk SF; Jose PA; Felder RA
    Mol Pharmacol; 1996 Feb; 49(2):373-8. PubMed ID: 8632772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
    Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
    Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A.
    Horiuchi A; Takeyasu K; Mouradian MM; Jose PA; Felder RA
    Mol Pharmacol; 1993 Feb; 43(2):281-5. PubMed ID: 8094227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.
    Castellano MA; Liu LX; Monsma FJ; Sibley DR; Kapatos G; Chiodo LA
    Mol Pharmacol; 1993 Sep; 44(3):649-56. PubMed ID: 8371717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D2-like receptor-mediated inhibition of Na+-K+-ATPase activity is dependent on the opening of K+ channels.
    Gomes P; Soares-Da-Silva P
    Am J Physiol Renal Physiol; 2002 Jul; 283(1):F114-23. PubMed ID: 12060593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells.
    Kanterman RY; Mahan LC; Briley EM; Monsma FJ; Sibley DR; Axelrod J; Felder CC
    Mol Pharmacol; 1991 Mar; 39(3):364-9. PubMed ID: 1848657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
    Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 stimulation of Na+,K+,Cl- cotransport in human NPE cells: effects of multiple hormones.
    Riese K; Beyer AT; Lui GM; Crook RB
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1444-52. PubMed ID: 9660493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine acutely decreases type 3 Na(+)/H(+) exchanger activity in renal OK cells through the activation of protein kinases A and C signalling cascades.
    Gomes P; Soares-da-Silva P
    Eur J Pharmacol; 2004 Mar; 488(1-3):51-9. PubMed ID: 15044035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genistein inhibits the regulation of active sodium-potassium transport by dopaminergic agonists in nonpigmented ciliary epithelium.
    Nakai Y; Dean WL; Hou Y; Delamere NA
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1460-6. PubMed ID: 10359328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors.
    O'Hara CM; Uhland-Smith A; O'Malley KL; Todd RD
    J Pharmacol Exp Ther; 1996 Apr; 277(1):186-92. PubMed ID: 8613917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 20-HETE in D1/D2 dopamine receptor synergism resulting in the inhibition of Na+-K+-ATPase activity in the proximal tubule.
    Kirchheimer C; Mendez CF; Acquier A; Nowicki S
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1435-42. PubMed ID: 17264308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1989 Feb; 248(2):514-20. PubMed ID: 2465405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
    Boundy VA; Pacheco MA; Guan W; Molinoff PB
    Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-induced desensitization of D2 dopamine receptors in human Y-79 retinoblastoma cells.
    Barton AC; Black LE; Sibley DR
    Mol Pharmacol; 1991 May; 39(5):650-8. PubMed ID: 1674585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins.
    Liu LX; Burgess LH; Gonzalez AM; Sibley DR; Chiodo LA
    Synapse; 1999 Feb; 31(2):108-18. PubMed ID: 10024007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C; Ebadi M; Govitrapong P
    J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na(+)-K(+)-ATPase activity.
    Gomes P; Soares-da-Silva P
    Am J Physiol Renal Physiol; 2002 Jun; 282(6):F1084-96. PubMed ID: 11997325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
    Yoshimura M; Ikeda H; Tabakoff B
    Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.